Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06128525 · ClinicalTrials.gov registry record · NA
Prostate Resection After Microwave Ablation (PRAMA)
A NA study, sponsored by University of Southern California.
- Completed
- Registry status
- NA
- Development phase
- 1
- Enrollment target
NCT06128525 is a NA study that has completed, run by University of Southern California. The registered enrollment target is 1 participants.
The verdict
NCT06128525, a NA study, has completed, sponsored by University of Southern California.
- COMPLETED
- Registry status
- NA
- Development phase
- 1 participants
- Enrollment target
Study Summary
This phase I trial tests the safety of magnetic resonance imaging (MRI)/ ultrasound (US) fusion guided transperineal targeted microwave ablation (TMA) before a radical prostatectomy (RP) and how well it works in treating patients with prostate cancer. Prostate cancer is the second most common cancer in men and most will never become aggressive. Despite this, most men choose to undergo treatment which may include surgery. Removing the prostate gland and sometimes the lymph nodes (radical prostatectomy) is an invasive treatment for prostate cancer that can have a significant negative on quality of life. TMA is a less invasive procedure that uses high temperatures given through the skin between the scrotum and the rectum (transperineal). Using focused high energy and heating tumor cells to several degrees above normal body temperature may kill them without affecting the surrounding tissue. Using multiparametric (mp)MRI/US to create a 3-dimensional picture of the tumor may help in planning and preventing damage to healthy tissue. Giving MRI/US fusion guided transperineal TMA prior to radical prostatectomy may kill tumor cells, and may improve the quality of life in patients with prostate cancer.
Interventions
- PROCEDURE Biospecimen Collection
- OTHER Questionnaire Administration
- PROCEDURE Radical Prostatectomy
- DEVICE Microwave Ablation
- DEVICE Multiparametric Magnetic Resonance Imaging
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2023-11-10 |
| Est. Completion | 2025-08-27 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06128525
The ClinicalTrials.gov registry entry for NCT06128525 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Southern California, which has 617 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Biospecimen Collection is the first listed.
NCT06128525 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06128525 about?
NCT06128525 is a clinical study titled "Prostate Resection After Microwave Ablation (PRAMA)". This phase I trial tests the safety of magnetic resonance imaging (MRI)/ ultrasound (US) fusion guided transperineal targeted microwave ablation (TMA) before a radical prostatectomy (RP) and how well it works in treating patients with prostate cancer. Prostate cancer is the second most common cancer...
What is the current status of trial NCT06128525?
This trial is currently completed. It is a NA study. The enrollment target is 1 participants. The study started on 2023-11-10. Estimated completion is 2025-08-27.
What interventions are being tested in trial NCT06128525?
The interventions under investigation include: Biospecimen Collection (PROCEDURE), Questionnaire Administration (OTHER), Radical Prostatectomy (PROCEDURE), Microwave Ablation (DEVICE), Multiparametric Magnetic Resonance Imaging (DEVICE).
Who is sponsoring clinical trial NCT06128525?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.